-
1
-
2
-
3
-
4
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
Published 2025-01-01Get full text
Article -
5
Unlocking the potential of engineered immune cell therapy for solid tumors
Published 2025-01-01Get full text
Article -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
Published 2025-01-01Get full text
Article -
14
-
15
-
16
-
17